Modular Medical Inc (MODD): Market Cap to Revenue

Symbol and logo of brand Modular Med (MODD)

Direct shipments of insulin pumps to patients optimize costs, establishing a positive trajectory for Modular Medical (MODD). The revenue multiple confirms the strength of the trend, with the current level sitting around . Capitalization growth is driven by scaling sales and insurance reimbursements, while assembly diversification and electronic warehouse reserves ensure business resilience against supply chain disruptions.

MODD Modular Med P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Modular Medical (MODD)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:MODD Modular Medical Inc
Core merchandise of Modular Medical, Inc.

Identifying assets with a high margin of safety requires analyzing market value relative to actual revenues. This ratio determines the price of each unit of revenue, allowing for an assessment of the premium paid for current sales volumes. For Modular Medical (MODD), this parameter reflects market expectations regarding the approval of new devices against the backdrop of electronics supply risks. The price action of the P/S multiple helps identify a dangerous disconnect between capitalization and actual demand in a timely manner.

Competitors of Modular Medical

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Treace Medical Concepts - P/S Multiple|Price-to-Revenue Coefficient blade.com SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Inc)|Price-to-Revenue Ratio ClearPoint Neuro Inc.|Market Cap to Revenue Stereotaxis Corporation (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical International - Market Cap to Sales Volume|vivani.com (VANI) - Price-to-Revenue Ratio|Market Cap to Revenue Xtant Medical|Price-to-Revenue Ratio NeuroOne Medical Technologies Corporation|Price to Sales Myomo Inc. MYO|P/S Multiple COCH|Vivos Therapeutics Inc - Market Cap to Revenue Ratio|enVVeno Medical - Market Cap to Revenue|P/S Multiple Sintx Technologies Inc SINT|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|AMIX: P/S Multiple|INVO Fertility Corp (IVF) - P/S Multiple|Price-to-Revenue Ratio Bone Biologics|AXNX: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue BIOL (BIOLASE)|DYNT (dynatronics.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Paragon 28 FNA|INVO - Market Cap to Revenue